DIAVACS, INC.

LA JOLLA, CA · Founded 2013 · CIK 0001575240 · Biotech · Defunct

Microsphere vaccine formulation containing antisense oligonucleotides targeting dendritic cells to suppress autoimmunity

diavacs.com →
Grants
$231K
1 award
Sector median: 1
Raised
$850K
3 Form D · Mar 2015
139 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$53
Private capital raisedForm D · SEC$90
Private capital raisedForm D · SEC$849,999
Federal grantDepartment of Health and Human Services · Phase I · Antisense-Loaded Microsphere Therapy for Autoimmune Diseases$231,153
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2766Florey Biosciences, Inc.—$1.4M
2767JSK THERAPEUTICS INC.—$963K
2768Wave Bye Inc.—$852K
2769DIAVACS, INC.—$850K
2770OCEANYX PHARMACEUTICALS, INC.——
2771Niche Biopharmaceuticals LLC—$525K
2772LACERTA THERAPEUTICS, INC.—$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Daniel BradburyDirector · Executive Officer
  • Alexander CasdinDirector
  • James GavinDirector
  • Haro HartounianDirector · Executive Officer
  • Alan LewisDirector
  • Edwin NaylorDirector
  • Vern NorvielExecutive Officer
  • Dietrich StephanDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.